Journal
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 71, Issue 23, Pages 2691-2701Publisher
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2018.04.030
Keywords
atrial fibrillation; fitness; cardiovascular disease; mHealth; mobile health; physical activity; prevention
Categories
Funding
- Amazon
- AstraZeneca
- Bristol-Myers Squibb
- Medtronic
- AHA
- Apple
- Janssen
- Cardiva Medical
- Boehringer Ingelheim
- Abbott
- iRhythm
- Precision Health
- Amgen
- Bayer
- Gilead
- Merck
- MyoKardia
- Medicines Company
- CSL Limited
- GlaxoSmithKline
- Novartis
- Portola
- Sanofi
Ask authors/readers for more resources
The growing recognition that health takes place outside of the hospital and clinic, plus recent advances in mobile and wearable devices, have propelled the field of mobile health (mHealth). Cardiovascular disease and prevention are major opportunities for mHealth, as mobile devices can monitor key physiological signals (e.g., physical activity, heart rate and rhythm) for promoting healthy behaviors, detecting disease, and aid in ongoing care. In this review, the authors provide an update on cardiovascular mHealth by highlighting recent progress and challenges with mobile and wearable devices for assessing and promoting physical activity and fitness, and for monitoring heart rate and rhythm for the detection and management of atrial fibrillation. (C) 2018 by the American College of Cardiology Foundation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available